More precisely, cancer cells preferentially splice pre-mRNA of the PKM gene to produce PKM2 rather than PKM1, the former possesses the ability to finely tune its activity in response to nutrient availability and to other different cellular signals [9]. The gene discussed is PKM; the disease is cancer.